Reference
Varughese T, et al. Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer. Clinical Infectious Diseases 67: 687-692, No. 5, 16 Aug 2018. Available from: URL: http://doi.org/10.1093/cid/ciy175 - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1731, 37 (2018). https://doi.org/10.1007/s40278-018-55232-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-55232-3